Adam Reynolds-Scott

Adam Reynolds-Scott is a Senior Scientist at Jazz Pharmaceuticals since March 2024, bringing extensive experience from Pfizer, where roles included Senior Scientist and lead for chromatographic purification in Phase III API development. Prior positions encompass Synthetic Chemist at Aptuit and leadership in product development at Toximet Ltd., focusing on Mycotoxin extraction technologies. Adam's career began at Evotec as a Development Chemist, specializing in the synthesis of pharmaceutical ingredients, complemented by research skills honed at the University of York. Academic credentials include a BSc in Chemistry from The University of Sheffield and an MSc in Modern Chemistry Laboratory Practices from Bangor University.